B7-33 (6mg)

Description

Advance your cardiovascular, tissue regeneration, and metabolic research with high-purity B7-33 (6mg).

B7-33 is a synthetic peptide specifically engineered as a non-helical, centrally active analog derived from the C-terminal sequence of Relaxin-2. In biochemical literature, Relaxin-2 and its peptide analogs are studied for their profound anti-fibrotic, vasodilatory, and tissue-remodeling properties. By selectively targeting and activating the relaxin family peptide receptor 1 (RXFP1), B7-33 initiates critical intracellular signaling cascades—including cAMP upregulation and matrix metalloproteinase modulation—while deliberately avoiding the unwanted structural and proliferative characteristics associated with the full-length hormone.

In laboratory and scientific settings, B7-33 serves as an essential experimental tool to investigate myocardial tissue protection, cardiac fibrosis mitigation, and extracellular matrix turnover. Researchers rely on this high-purity 6mg formulation to explore advanced cardioprotective pathways, organ remodeling dynamics, and anti-fibrotic signaling mechanisms in controlled in vitro and in vivo environments.

Key Research Benefits

• RXFP1 Receptor Activation: Selectively binds to relaxin family receptor 1 to model cardiovascular signaling and cellular protection cascades.

• Anti-Fibrotic & Tissue Remodeling Studies: Serves as a benchmark compound for investigating extracellular matrix regulation and collagen deposition mitigation.

• Myocardial & Vascular Protection: Facilitates precise experimental observation of cardioprotective pathways, vasodilation, and tissue resilience.

• High-Purity Formulation: Engineered to stringent laboratory standards to guarantee structural stability, batch consistency, and reliable assay performance.

Usage & Handling Guide

• For Laboratory and Research Use Only: Strictly designated for scientific research, in vitro studies, and laboratory experimentation. Not intended for human consumption, clinical application, diagnostic procedures, or veterinary use.

• Reconstitution & Storage: Reconstitute using sterile bacteriostatic water or compatible laboratory buffers according to your experimental protocol. Store lyophilized powder at -20°C. Keep refrigerated between 2°C–8°C post-reconstitution.

Disclaimer: Purchaser assumes all responsibility for safe handling, appropriate laboratory protocols, and compliance with all local regulatory guidelines governing research chemicals.